title: Should all patients with systemic lupus erythematosus receive cardioprotection with statins?
authors: Centre for Prognosis Studies in the Rheumatic Diseases at Toronto Western Hospital, in Toronto, ON, Canada.
authors: Sergio
authors: S
authors: Toloza
authors: Murray B
authors: MB
authors: Urowitz
authors: Dafna D
authors: DD
authors: Gladman
mesh_terms: D050197:Atherosclerosis / Q000188:drug therapy* / Q000209:etiology; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors